tiragolumab
Rocheās TIGIT Therapy: ESMO Reveals Ongoing Commitment
Anika Sharma
Roche is taking a steadfast position in the realm of TIGIT-class therapies, even in the face of fluctuating data and ...
Roche Unveils Interim TIGIT Overall Survival Data Following Unintended Release, Triggering Surge in Stocks
Anika Sharma
An unexpected revelation has provided the world with a sneak peek into Roche’s highly anticipated TIGIT data. Roche, which had ...
